Intestinal Permeability and “Leaky Gut”: What the Science Actually Shows
The term “leaky gut” has become so common that it is sometimes treated either as the explanation for nearly every chronic symptom or dismissed as something that is not medically real. Neither position is particularly useful.
Intestinal permeability is normal physiology. The intestinal lining has to allow nutrients, water, electrolytes, and other needed substances to move through while limiting inappropriate passage of microorganisms, microbial products, toxins, and larger molecules. When that regulation is disturbed and the barrier becomes more permeable than it should be, researchers refer to increased intestinal permeability or intestinal-barrier dysfunction. “Leaky gut” is often used as shorthand for the same phenomenon.
Increased permeability has been documented in celiac disease, inflammatory bowel disease, gastrointestinal infections, critical illness, and other conditions. It also appears in subsets of people with irritable bowel syndrome and has been studied in obesity, insulin resistance, fatty liver disease, and other inflammatory states.
Where the language gets ahead of the evidence is “leaky gut syndrome,” used as a broad diagnosis for bloating, fatigue, brain fog, food reactions, joint pain, skin problems, or almost any other symptom. Those symptoms deserve evaluation, but they do not by themselves tell us that intestinal permeability is abnormal. Good gut medicine begins with the physiology and the patient, not the catch phrase.
For many years, conversations about “leaky gut” tended to fall into two camps. In some parts of integrative medicine, virtually any chronic symptom could be attributed to a damaged intestinal barrier. In more conventional settings, the term itself was sometimes dismissed because “leaky gut syndrome” was not an established diagnosis.
The science has become more interesting than either position.
We now know much more about the intestinal epithelium, tight junctions, mucus, immune cells, microbial metabolites, and the signaling that takes place between the gut and the rest of the body. Modern gastroenterology literature routinely discusses intestinal-barrier dysfunction and increased intestinal permeability. Researchers sometimes even use the term “leaky gut” to describe that state.
What we do not have is a single disease called leaky gut that can be diagnosed from a list of nonspecific symptoms or one commercial laboratory marker.
This article is part of the HormoneSynergy® Gut Health, Microbiome, and Longevity Medicine Guide.
What Is Intestinal Permeability?
The intestinal lining is not supposed to be completely impermeable. If it were, digestion would not work.
Digested amino acids, fatty acids, carbohydrates, vitamins, minerals, water, and electrolytes all have to move from the intestinal lumen across the epithelial barrier. The body regulates that movement through several mechanisms, including transport through intestinal cells themselves and movement between neighboring cells through structures controlled in part by tight junctions.
When permeability is appropriately regulated, the intestine can absorb what the body needs while maintaining separation between the immune system and much of what remains inside the gut.
When researchers talk about increased intestinal permeability, they mean that this barrier has become more permissive than expected. Depending on the underlying process, microbial fragments, antigens, or other substances may have greater access to the intestinal immune system and, in some circumstances, the circulation.
That is the biological process most people are describing when they use the words “leaky gut.”
The terminology is less important than understanding what has caused the barrier disturbance and what should be done about it.
The Intestinal Barrier Is More Than Tight Junctions
Internet diagrams often portray the gut barrier as a row of intestinal cells that either fit tightly together or develop gaps. Tight junctions are important, but the actual barrier is considerably more sophisticated.
The first layer is the intestinal contents themselves, including food, digestive secretions, bile acids, microorganisms, and the enormous variety of metabolites those organisms produce. A mucus layer helps separate many microbes from direct contact with the intestinal epithelium. Beneath that is a single layer of epithelial cells that performs absorption, secretion, immune signaling, and physical containment.
Those cells are joined by tight junctions and other structural connections that regulate what can move between them. They also turn over rapidly, giving the intestinal lining a considerable capacity for renewal.
The immune system is woven throughout this environment. Secretory IgA, antimicrobial peptides, lymphoid tissue, macrophages, lymphocytes, and other immune components continually distinguish between normal dietary and microbial exposure and something that requires a defensive response.
The microbiome is part of the barrier system as well. Resident microorganisms interact with mucus, compete with potential pathogens, metabolize dietary compounds, and produce substances such as short-chain fatty acids that can influence epithelial and immune function.
Blood flow, the enteric nervous system, autonomic signaling, hormones, nutrition, sleep, stress physiology, and metabolic health all affect this environment. The intestinal barrier is therefore better understood as a living biological interface than as a wall that simply needs to be “sealed.”
What Can Disrupt Intestinal Barrier Function?
There is no single cause of increased intestinal permeability. The mechanism depends on the patient and the condition.
Celiac Disease
Celiac disease is one of the clearest examples. In genetically susceptible people, gluten exposure triggers an immune response that damages the small-intestinal lining and changes barrier regulation. Removing gluten is essential treatment once the diagnosis has been established.
If celiac disease is being considered, testing should generally be performed while the person is still consuming gluten. Going gluten-free first can make the diagnostic evaluation less reliable.
Inflammatory Bowel Disease
Crohn’s disease and ulcerative colitis involve chronic immune-mediated intestinal inflammation. Barrier disruption is part of that biology. Inflammation can injure the epithelial lining and alter permeability, while increased exposure to luminal microbial products may further stimulate immune activity.
The relationship is not simply one-way, which is one reason treating the underlying inflammatory disease is more important than treating permeability as though it were an independent diagnosis.
Gastrointestinal Infection
Bacterial, viral, and parasitic infections can injure intestinal epithelial cells, alter junctional regulation, disrupt the microbiome, and activate mucosal immunity. Barrier function often improves as an infection resolves, although some people are left with persistent gastrointestinal symptoms or post-infectious disorders of gut-brain interaction.
Medications
Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen can damage gastrointestinal mucosa and affect intestinal permeability, particularly when used frequently or at higher doses. Chemotherapy, radiation, antibiotics, and other treatments can alter the intestinal environment through different mechanisms.
This does not mean that medically necessary medications should automatically be stopped in an effort to “heal the gut.” Medication exposure is one part of the clinical history and should be evaluated in context.
Alcohol
Repeated heavy alcohol exposure can affect epithelial integrity, tight-junction regulation, the microbiome, inflammatory signaling, and the liver. Because the gut and liver communicate directly through the portal circulation, alcohol-related intestinal changes are increasingly studied as part of the gut-liver axis.
Critical Illness and Intestinal Injury
Sepsis, major burns, trauma, reduced intestinal blood flow, severe infection, and critical illness can produce substantial intestinal-barrier dysfunction. These are dramatic examples of the same general physiology, although they are very different clinically from the more modest changes often discussed in outpatient gut-health care.
Diet and Metabolic Health
Diet also shapes the intestinal environment. Fiber intake, food diversity, fat quality, alcohol, ultra-processed foods, and the availability of fermentable substrates influence microbial metabolism and the compounds bathing the epithelial surface.
Obesity, insulin resistance, metabolic dysfunction-associated steatotic liver disease, and visceral adiposity have been associated with altered intestinal-barrier markers in human studies. The relationship appears to be bidirectional in at least some settings. Metabolic inflammation may affect the gut barrier, while gut-derived microbial products may contribute to inflammatory signaling.
That is biologically plausible and increasingly well studied, but it does not mean that every person with insulin resistance has a leaky gut or that correcting permeability alone will reverse metabolic disease.
So Is “Leaky Gut” Real?
If by leaky gut we mean abnormally increased intestinal permeability or impaired intestinal-barrier function, yes. That biology is well established.
If by “leaky gut syndrome” we mean a single diagnosable disorder responsible for almost any combination of fatigue, bloating, brain fog, headaches, joint discomfort, skin problems, food reactions, mood symptoms, autoimmune disease, or weight gain, the evidence is much less convincing.
Those symptoms can occur in people who also have abnormal barrier function, but they are not specific to it. Bloating may come from lactose intolerance, constipation, small-intestinal bacterial overgrowth, celiac disease, irritable bowel syndrome, or altered motility. Fatigue may reflect anemia, thyroid dysfunction, sleep apnea, medication effects, depression, nutritional deficiency, metabolic disease, or dozens of other causes.
The concern is not the use of the phrase “leaky gut.” It is allowing the phrase to replace a diagnosis.
A patient can have intestinal-barrier dysfunction and still need evaluation for celiac disease. A patient can have dysbiosis and still have inflammatory bowel disease. A patient can improve with dietary changes and still have an iron deficiency that needs to be explained.
Good clinical medicine keeps those possibilities open.
The Microbiome and the Gut Barrier
The microbiome and the intestinal barrier are closely connected, although the relationship is more complicated than simply having enough “good bacteria.”
Resident microbes compete with pathogens, interact with mucus, modify bile acids, metabolize polyphenols and fibers, and produce compounds that influence epithelial and immune cells. Among the best studied are the short-chain fatty acids acetate, propionate, and butyrate.
Butyrate is particularly interesting because colonocytes can use it as an energy source. It has also been associated with mucus production, immune regulation, and tight-junction function. Dietary fibers and resistant starches provide substrates that selected intestinal organisms can ferment into these metabolites.
That does not mean everyone should simply take more fiber. Someone with severe bloating, active inflammatory bowel disease, intestinal narrowing, significant gastroparesis, or particular fermentative symptoms may need a more individualized approach.
Microbiome composition is also highly contextual. An organism may behave differently depending on the strain, the surrounding microbial community, available nutrients, location within the gastrointestinal tract, medications, and the health of the host.
For more on this physiology, see Butyrate and Short-Chain Fatty Acids: Why Your Gut Bacteria Make Them.
Intestinal Permeability, Inflammation, and Metabolic Health
One reason intestinal permeability has attracted so much research interest is that the gut is in constant communication with the immune system and the rest of the body.
When microbial products gain greater access to the intestinal immune system or circulation, they can stimulate inflammatory pathways. Lipopolysaccharide, or LPS, is one of the best-known examples. It is a component of the outer membrane of certain Gram-negative bacteria and has been studied extensively in connection with immune activation and metabolic inflammation.
Experimental work provides strong evidence that gut-derived microbial signals can influence metabolism. Human studies have also reported relationships among markers associated with barrier dysfunction, visceral adiposity, insulin resistance, fatty liver disease, and cardiovascular risk.
The difficult question is causality. People with metabolic disease often have changes in diet, bile acids, inflammation, intestinal motility, medications, microbiota, and immune signaling at the same time. A permeability marker by itself cannot establish which part of that biology came first.
For that reason, we would not substitute an intestinal permeability test for established metabolic assessment. Blood pressure, waist circumference, body composition, glucose, A1C, fasting insulin when appropriate, triglycerides, HDL, ApoB, liver enzymes, and other conventional measurements remain far more actionable in routine patient care.
For a deeper discussion, see LPS, Metabolic Endotoxemia, and Chronic Inflammation.
What About IBS?
Irritable bowel syndrome offers a good example of why intestinal permeability should not be treated as an all-or-nothing diagnosis.
Some people with IBS, particularly diarrhea-predominant and post-infectious IBS, show increased intestinal permeability in research studies. Others do not. Recent gastroenterology reviews describe barrier dysfunction as one possible component of disorders of gut-brain interaction rather than the sole explanation for them.
IBS can involve altered motility, visceral sensitivity, immune activity, microbial changes, diet, bile acids, stress physiology, and communication between the intestinal and central nervous systems. Barrier function may be part of that picture in an individual patient, but IBS and leaky gut are not interchangeable diagnoses.
Can We Test Intestinal Permeability?
Yes, but testing is not as simple as some commercial programs suggest.
Oral Sugar-Probe Testing
One of the more established research approaches uses orally administered molecules of different sizes, followed by measurement in urine or blood. Lactulose and mannitol have traditionally been used to assess aspects of small-intestinal permeability, while other combinations can provide information about different gastrointestinal regions.
These tests can be useful, particularly in research, but results are influenced by intestinal transit, gastric emptying, kidney function, hydration, urine collection, diet, medication use, laboratory technique, and the specific molecules being measured. Methods and normal ranges are not completely standardized.
Zonulin
Zonulin-related signaling is legitimate intestinal biology and has been studied extensively in celiac disease and barrier regulation. The difficulty is translating that biology into a routine commercial blood or stool test.
Research has shown that some widely used commercial zonulin immunoassays may detect proteins other than pre-haptoglobin 2, the molecule originally described as zonulin. Serum measurements have also not consistently tracked with direct permeability measurements.
A zonulin result can therefore be part of a research question, but it should not be treated as proof that a patient has “leaky gut syndrome.”
Stool Testing
Stool testing can provide useful information, depending on what is being measured. Fecal calprotectin, for example, is an established marker of intestinal inflammation and can be extremely helpful when inflammatory bowel disease is being considered or monitored.
Microbiome profiles, pancreatic elastase, secretory IgA, digestive markers, pathogens, and other stool measurements address different questions. A stool sample does not directly measure how readily molecules are crossing the small-intestinal epithelium.
Food-IgG Testing
Food-specific IgG is generally evidence that the immune system has encountered a food, not proof that the food is leaking through the intestine or causing intolerance. Broad food-IgG panels frequently identify foods that a person eats regularly and can lead to unnecessarily restrictive diets when interpreted as allergy or intestinal permeability testing.
Testing should answer a clinical question. Ordering more markers does not automatically produce more useful information.
Supporting Intestinal-Barrier Recovery
The intestinal lining is one of the body's most actively renewing tissues. That gives it an impressive capacity for repair, but recovery depends on what is disturbing the barrier in the first place.
Someone with celiac disease needs a gluten-free diet. Someone with inflammatory bowel disease may need anti-inflammatory or immune-directed treatment. An infection may require antimicrobial therapy or simply time and supportive care, depending on the organism. Frequent NSAID exposure may need to be reconsidered. Heavy alcohol intake deserves attention regardless of whether permeability has been measured.
For people without a specific intestinal disease, the same habits that support metabolic and cardiovascular health tend to create a favorable environment for the gut as well.
Feed the Intestinal Environment
A plant- and protein-forward Mediterranean dietary pattern supplies fermentable fibers, polyphenols, vitamins, minerals, essential fats, and adequate protein for tissue maintenance. Vegetables, fruits, legumes, whole grains, nuts, seeds, herbs, spices, and other plant foods provide substrates that different microbial communities can use.
Dietary diversity is often more useful than searching for one “gut-healing” food.
Support Microbial Fermentation When Tolerated
Fiber and resistant starch can encourage the production of short-chain fatty acids, including butyrate. Increasing these foods gradually is often better tolerated than abruptly introducing large doses of isolated prebiotics.
Some people need temporary dietary modifications because of active gastrointestinal disease or significant symptoms. The objective is not to force a high-fiber diet onto every patient but to build the broadest nutritionally adequate diet that the person can comfortably tolerate.
Protect Sleep, Activity, and Metabolic Health
Exercise, adequate sleep, and improving insulin sensitivity affect immune regulation and systemic inflammation as well as intestinal physiology. These interventions do not have to be sold as “gut healing” to be valuable to the gut.
Limit Excess Alcohol and Avoid Unnecessary Irritants
Reducing heavy alcohol exposure can benefit intestinal integrity, liver function, sleep, blood pressure, and metabolic health simultaneously. Frequent NSAID use and unnecessary antibiotic exposure should also be reviewed when clinically appropriate.
Use Supplements for a Reason
Supplements can have a place in a gut-health plan, particularly when the objective is clear. They should not become a mandatory protocol given to everyone who has bloating or fatigue.
Glutamine and Gut-Lining Support
Glutamine is an important metabolic fuel for intestinal cells and has been studied in a variety of conditions involving intestinal stress, injury, and altered permeability. Results vary considerably by population and clinical setting, so the evidence does not support describing glutamine as something that simply “seals” every leaky gut.
RetzlerRx® Glutamine Synergy combines L-glutamine with deglycyrrhizinated licorice and aloe for patients in whom targeted intestinal-tissue and digestive support is appropriate.*
RetzlerRx® Leaky Gut Support provides glutamine with arabinogalactan, DGL, and aloe in capsules for people who prefer that delivery form.*
Serum-Derived Immunoglobulins
Serum-derived bovine immunoglobulins largely remain within the gastrointestinal tract, where they may bind selected microbial antigens and support mucosal immune function. Human evidence is strongest in specific gastrointestinal populations rather than as a universal therapy for intestinal permeability.*
See MegaIgG2000 Powder vs. Capsules for a practical comparison of available forms.
Probiotics
Specific probiotic organisms can influence microbial ecology, immune signaling, fermentation, and aspects of epithelial-barrier function. Effects are strain- and product-specific, which is why the word “probiotic” should not be interpreted as though every product has the same clinical effect.
MegaSporeBiotic™ is a spore-based probiotic that has been studied in relation to gastrointestinal and intestinal-barrier markers. As with other probiotics, response and tolerance vary.*
Polyphenols and Prebiotic Foods
Another strategy is to nourish organisms already living in the intestinal ecosystem rather than adding more organisms. Polyphenols, resistant starches, and fermentable plant compounds can influence microbial metabolism and the compounds produced in the colon.
Big Bold Health Microbiome Rejuvenate uses sprouted Himalayan Tartary buckwheat as a source of whole-food polyphenols, resistant starches, and prebiotic fibers. People who are very sensitive to fermentable carbohydrates may need to introduce products of this type gradually.*
These are options, not a required “leaky gut protocol.” Most patients would not need every product. Selection should reflect the clinical problem, diet, symptoms, tolerance, medication use, and any established gastrointestinal diagnosis.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent disease. Supplements should support, not replace, appropriate medical evaluation and treatment.
When Gut Symptoms Deserve More Than a Gut Protocol
Most bloating, food-related discomfort, or intermittent changes in bowel habits are not emergencies. Persistent symptoms deserve more careful evaluation, particularly when they occur with blood in the stool, black stools, unexplained weight loss, iron-deficiency anemia, fever, recurrent vomiting, nighttime diarrhea or pain, difficulty swallowing, a strong family history of gastrointestinal disease, or new unexplained symptoms later in adulthood.
Those situations should not be managed indefinitely with elimination diets, probiotics, digestive supplements, or the assumption that the intestine simply needs to be “sealed.”
A HormoneSynergy® Perspective
Intestinal permeability is not fringe physiology. The intestinal barrier is actively studied in gastroenterology, immunology, metabolic medicine, hepatology, and neuroscience, and our understanding of it continues to expand.
We also do not think every symptom needs to be folded into a diagnosis called leaky gut.
At HormoneSynergy®, gut health is considered within the rest of the patient's physiology: gastrointestinal symptoms, diet, medication exposure, microbiome, metabolic health, inflammatory conditions, sleep, stress physiology, body composition, and appropriate conventional testing.
Sometimes supporting the intestinal lining or microbiome is entirely reasonable. Sometimes the more important intervention is treating celiac disease, addressing inflammatory bowel disease, reducing alcohol, correcting a nutrient deficiency, changing a medication, improving insulin resistance, or simply eating a better diet.
The language we use should help us understand the physiology rather than replace it. That is the difference between treating “leaky gut” as a catch phrase and taking intestinal-barrier health seriously.
Frequently Asked Questions
Is leaky gut real?
Yes, if the term is being used to describe increased intestinal permeability or intestinal-barrier dysfunction. These are recognized physiological phenomena. “Leaky gut syndrome,” however, is not a standardized diagnosis that can be established from nonspecific symptoms alone.
Is intestinal permeability always abnormal?
No. The intestine must be selectively permeable in order to absorb nutrients, water, and electrolytes. The concern is inappropriate or excessive permeability associated with altered barrier function or mucosal injury.
What conditions are associated with increased intestinal permeability?
Increased permeability is well established in conditions including celiac disease, inflammatory bowel disease, gastrointestinal infections, and severe intestinal injury. It has also been identified in subsets of patients with IBS and studied in metabolic, liver, inflammatory, and other disorders.
What are the symptoms of increased intestinal permeability?
There is no symptom pattern that specifically diagnoses permeability. Bloating, diarrhea, abdominal discomfort, fatigue, food-related symptoms, and other complaints may occur in people who have barrier dysfunction, but those symptoms have many other possible causes.
What is the best test for leaky gut?
Oral probe tests using sugars of different sizes are among the better-established methods for assessing intestinal permeability in research and selected clinical settings. There is currently no single routine blood or stool test that provides a complete assessment of intestinal-barrier function.
Does zonulin prove that someone has leaky gut?
No. Zonulin biology is relevant to intestinal-barrier regulation, but currently available commercial assays have important analytical and clinical limitations. A zonulin result should not be interpreted as a stand-alone diagnosis.
Does a stool microbiome test measure permeability?
No. Stool testing can provide information about organisms, inflammation, digestion, pathogens, and selected microbial functions, depending on the assay. It does not directly measure movement of substances across the intestinal lining.
Can diet improve intestinal-barrier health?
Diet can influence the microbiome, mucus, microbial metabolites, immune activity, and epithelial nutrition. A diverse Mediterranean-style dietary pattern rich in plants, adequate protein, fiber when tolerated, and minimally processed foods provides a reasonable foundation for most people.
Can probiotics or glutamine help?
They may help in selected circumstances, but effects depend on the product, dose, underlying condition, and individual patient. Neither probiotics nor glutamine should be treated as universal therapies for every person believed to have a “leaky gut.”
Selected References
- Grover M, Vanuytsel T, Chang L. Intestinal permeability in disorders of gut-brain interaction: From bench to bedside. Gastroenterology. 2025;168(3):480-495.
- Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterology & Hepatology. 2025;10(6):573-592.
- Turner JR. Tight junction regulation, intestinal permeability, and mucosal immunity in gastrointestinal health and disease. Current Opinion in Gastroenterology. 2025.
- Compare D, Sgamato C, Rocco A, et al. The leaky gut and human diseases. Digestive Diseases. 2024;42(6):548-566.
- Güemes-González AM, Arriaga-Pizano LA, Chacón-Salinas R, et al. Regulation of intestinal permeability in health and disease: possible therapeutic applications. Archives of Medical Research. 2026;57(3):103321.
- Khoshbin K, Khanna L, Maselli D, et al. Development and validation of a test for leaky gut small intestinal and colonic permeability using sugars in healthy adults. Gastroenterology. 2021;161(2):463-475.e13.
- Scheffler L, Crane A, Heyne H, et al. Widely used commercial ELISA does not detect precursor of haptoglobin 2 but recognizes properdin as a potential second member of the zonulin family. Frontiers in Endocrinology. 2018;9:22.
This article is for educational purposes and does not replace individualized medical evaluation, diagnosis, or treatment. Persistent or concerning gastrointestinal symptoms should be assessed by an appropriately qualified clinician.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →